IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
* Reuters is not responsible for the content in this press release.
IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial
Results
WESTBROOK, Maine, Jan. 15 /PRNewswire-FirstCall/ -- IDEXX Laboratories,
Inc. (Nasdaq: IDXX), has scheduled the release of its 2007 fourth quarter and
full-year financial results for Friday, January 25, at approximately 7:00 a.m.
(eastern). The Company will conduct an analyst conference call beginning at
9:00 a.m. (eastern) on that day.
Individuals can access a live Webcast of the conference call through a
link on the IDEXX Web site, www.idexx.com. An archived edition of the call
will be available after 1:00 p.m. (eastern) on that day via the same link.
The live call also will be accessible by telephone. To listen to the live
conference call, please dial 719-325-4782 or 877-723-9502 and reference
confirmation code 3405969. Replay of the conference call will be available as
of 12:00 p.m. (eastern) on January 25, through Friday, February 1, by dialing
719-457-0820 and referencing replay code 3405969.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in companion animal health, serving
practicing veterinarians around the world with innovative, technology-based
offerings, including a broad range of diagnostic products and services,
practice-management systems and pharmaceuticals. IDEXX products enhance the
ability of veterinarians to provide advanced medical care and to build more
economically successful practices. IDEXX is also a worldwide leader in
providing diagnostic tests and information for the production animal industry
and tests for the quality and safety of water and milk. Headquartered in
Maine, IDEXX Laboratories employs more than 4,500 people and offers products
to customers in over 100 countries.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030305/IDEXXLOGO )
Contact: Bonnie Reid, Investor Relations, 1-207-556-4548
SOURCE IDEXX Laboratories, Inc.
Bonnie Reid of IDEXX Laboratories, Inc., Investor Relations, +1-207-556-4548
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters